• +1-646-491-9876
    • +91-20-67278686

    Search

    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2016

    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2016

    • Report Code ID: RW0001499777
    • Category Pharmaceuticals
    • No. of Pages 32
    • Publication Month Nov-16
    • Publisher Name Global Markets Direct
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2016

    Summary

    Publisher's, 'Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2016', provides in depth analysis on Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted pipeline therapeutics.

    The report provides comprehensive information on the Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics development and features dormant and discontinued projects.

    Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

    Note:
    *Certain sections in the report may be removed or altered based on the availability and relevance of data.
    *Updated report will be delivered in 48 hours of order confirmation.

    Scope

    - The report provides a snapshot of the global therapeutic landscape for Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9)
    - The report reviews Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
    - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
    - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
    - The report reviews key players involved in Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics and enlists all their major and minor projects
    - The report assesses Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
    - The report summarizes all the dormant and discontinued pipeline projects
    - The report reviews latest news and deals related to Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics

    Reasons to buy

    - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
    - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
    - Identify and understand the targeted therapy areas and indications for Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9)
    - Identify the use of drugs for target identification and drug repurposing
    - Identify potential new clients or partners in the target demographic
    - Develop strategic initiatives by understanding the focus areas of leading companies
    - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
    - Devise corrective measures for pipeline projects by understanding Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) development landscape
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
    Table of Contents

    List of Tables 3
    List of Figures 4
    Introduction 5
    Publisher Report Coverage 5
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) Overview 6
    Therapeutics Development 7
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Products under Development by Stage of Development 7
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Products under Development by Therapy Area 8
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Products under Development by Indication 9
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Products Glance 10
    Late Stage Products 10
    Early Stage Products 11
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Products under Development by Companies 12
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Products under Development by Universities/Institutes 14
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Therapeutics Assessment 16
    Assessment by Monotherapy/Combination Products 16
    Assessment by Mechanism of Action 17
    Assessment by Route of Administration 18
    Assessment by Molecule Type 19
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Companies Involved in Therapeutics Development 20
    Pfizer Inc. 20
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drug Profiles 21
    CSTI-200 - Drug Profile 21
    Product Description 21
    Mechanism Of Action 21
    R&D Progress 21
    DNS-006 - Drug Profile 22
    Product Description 22
    Mechanism Of Action 22
    R&D Progress 22
    PF-03463275 - Drug Profile 23
    Product Description 23
    Mechanism Of Action 23
    R&D Progress 23
    PGW-5 - Drug Profile 25
    Product Description 25
    Mechanism Of Action 25
    R&D Progress 25
    Small Molecule to Inhibit GlyT1 for Schizophrenia and Parkinson's Disease - Drug Profile 26
    Product Description 26
    Mechanism Of Action 26
    R&D Progress 26
    VU-0410120 - Drug Profile 27
    Product Description 27
    Mechanism Of Action 27
    R&D Progress 27
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Dormant Projects 28
    Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Discontinued Products 30
    Appendix 31
    Methodology 31
    Coverage 31
    Secondary Research 31
    Primary Research 31
    Expert Panel Validation 31
    Contact Us 31
    Disclaimer 32

    List of Tables

    Number of Products under Development for, H2 2016 7
    Number of Products under Development by Therapy Area, H2 2016 8
    Number of Products under Development by Indication, H2 2016 9
    Comparative Analysis by Late Stage Development, H2 2016 10
    Comparative Analysis by Early Stage Products, H2 2016 11
    Number of Products under Development by Companies, H2 2016 12
    Products under Development by Companies, H2 2016 13
    Number of Products under Investigation by Universities/Institutes, H2 2016 14
    Products under Investigation by Universities/Institutes, H2 2016 15
    Assessment by Monotherapy/Combination Products, H2 2016 16
    Number of Products by Stage and Mechanism of Action, H2 2016 17
    Number of Products by Stage and Route of Administration, H2 2016 18
    Number of Products by Stage and Molecule Type, H2 2016 19
    Pipeline by Pfizer Inc., H2 2016 20
    Dormant Projects, H2 2016 28
    Dormant Projects (Contd..1), H2 2016 29
    Discontinued Products, H2 2016 30

    List of Figures

    Number of Products under Development for, H2 2016 7
    Number of Products under Development by Top 10 Indication, H2 2016 9
    Assessment by Monotherapy/Combination Products, H2 2016 16
    Number of Products by Stage and Mechanism of Actions, H2 2016 17
    Number of Products by Stage and Molecule Type, H2 2016 19
    Pfizer Inc.

    Request for Sample

    Report Url http://www.reportsweb.com//sodium-and-chloride-dependent-glycine-transporter-1-pipeline-review-h2-2016&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//sodium-and-chloride-dependent-glycine-transporter-1-pipeline-review-h2-2016&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//sodium-and-chloride-dependent-glycine-transporter-1-pipeline-review-h2-2016&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments